If the price will be cheaper in a few weeks, then we can all celebrate the fact that those silly directors paid above market. But we won't will we? Because this glass is always half empty...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025